{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:42:39Z","timestamp":1781487759529,"version":"3.54.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06091-7","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:37:55Z","timestamp":1774082275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond anti-SSA and anti-SSB. The clinical significance of new antibodies in the diagnosis of Sj\u00f6gren disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6008-0563","authenticated-orcid":false,"given":"Aleksandra","family":"Oko\u0144","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-375X","authenticated-orcid":false,"given":"Joanna","family":"Makowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-8497","authenticated-orcid":false,"given":"Olga","family":"Brzezi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,21]]},"reference":[{"key":"6091_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41584-025-01268-z","volume":"21","author":"M Ramos-Casals","year":"2025","unstructured":"Ramos-Casals M, Baer AN, Brito-Zer\u00f3n M, del Hammitt P, Bouillot KM, Retamozo C S, et al (2025) 2023 International Rome consensus for the nomenclature of Sj\u00f6gren disease. Nat Rev Rheumatol 21:426\u2013437. https:\/\/doi.org\/10.1038\/s41584-025-01268-z","journal-title":"Nat Rev Rheumatol"},{"key":"6091_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/ard-2022-223105","volume":"82","author":"S Longobardi","year":"2023","unstructured":"Longobardi S, Lopez-Davis C, Khatri B, Georgescu C, Pritchett-Frazee C, Lawrence C et al (2023) Autoantibodies identify primary Sj\u00f6gren\u2019s syndrome in patients lacking serum IgG specific for Ro\/SS-A and La\/SS-B. Ann Rheum Dis 82:1181\u20131190. https:\/\/doi.org\/10.1136\/ard-2022-223105","journal-title":"Ann Rheum Dis"},{"key":"6091_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al (2017) 2016 ACR\/EULAR classification criteria for primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 69:35\u201345. https:\/\/doi.org\/10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"6091_CR4","doi-asserted-by":"publisher","first-page":"e46207","DOI":"10.7759\/cureus.46207","volume":"15","author":"RR Goel","year":"2023","unstructured":"Goel RR, Jeranko M, Jones L, Bishnoi A, Meysami A (2023) Diagnostic utility of minor salivary gland biopsy for primary Sj\u00f6gren syndrome in patients with negative anti-SSA antibodies. Cureus 15:e46207. https:\/\/doi.org\/10.7759\/cureus.46207","journal-title":"Cureus"},{"key":"6091_CR5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.55563\/clinexprheumatol\/ou4fx6","volume":"42","author":"S Liu","year":"2024","unstructured":"Liu S, Chen C, Zheng Q, Sun H, Yang C, Wang B et al (2024) Non-negligible prevalence of focal lymphocytic sialadenitis in minor salivary glands of non-Sj\u00f6gren\u2019s disease individuals. Clin Exp Rheumatol 42:2499\u20132506. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ou4fx6","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR6","doi-asserted-by":"publisher","first-page":"e83090","DOI":"10.7759\/cureus.83090","volume":"17","author":"D Saparov","year":"2025","unstructured":"Saparov D, Markov A, Choi S, Gold-Olufadi S, Becerra H, Barakat P et al (2025) Challenges in diagnosing and differentiating IgG4-related disease from Sj\u00f6gren\u2019s disease: a case report and literature review. Cureus 17:e83090. https:\/\/doi.org\/10.7759\/cureus.83090","journal-title":"Cureus"},{"key":"6091_CR7","doi-asserted-by":"publisher","first-page":"1524940","DOI":"10.3389\/fimmu.2025.1524940","volume":"16","author":"F Engelke","year":"2025","unstructured":"Engelke F, Budde P, De Vita S, D\u00f6rner T, Ernst D, Gras J et al (2025) Identification of novel autoantibodies in Sj\u00f6gren\u2019s disease. Front Immunol 16:1524940. https:\/\/doi.org\/10.3389\/fimmu.2025.1524940","journal-title":"Front Immunol"},{"key":"6091_CR8","doi-asserted-by":"publisher","first-page":"10007","DOI":"10.1038\/s41598-022-10007-3","volume":"12","author":"M Chen","year":"2022","unstructured":"Chen M, Zhou Y, Xue M, Zhu R, Jing L, Lin L et al (2022) Anti-HMGB1 antibody is a potential characteristic autoantibody for Sj\u00f6gren\u2019s syndrome. Sci Rep 12:10007. https:\/\/doi.org\/10.1038\/s41598-022-10007-3","journal-title":"Sci Rep"},{"key":"6091_CR9","doi-asserted-by":"publisher","first-page":"606195","DOI":"10.1155\/2012\/606195","volume":"2012","author":"R Yoshimi","year":"2012","unstructured":"Yoshimi R, Ueda A, Ozato K, Ishigatsubo Y (2012) Clinical and pathological roles of Ro\/SSA autoantibody system. Clin Dev Immunol 2012:606195. https:\/\/doi.org\/10.1155\/2012\/606195","journal-title":"Clin Dev Immunol"},{"key":"6091_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12935-023-03143-x","volume":"23","author":"C-H Hsu","year":"2023","unstructured":"Hsu C-H, Yu Y-L (2023) The interconnected roles of TRIM21\/Ro52 in systemic lupus erythematosus, primary Sj\u00f6gren\u2019s syndrome, cancers, and cancer metabolism. Cancer Cell Int 23:289. https:\/\/doi.org\/10.1186\/s12935-023-03143-x","journal-title":"Cancer Cell Int"},{"key":"6091_CR11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/10409238.2019.1608902","volume":"54","author":"M Boccitto","year":"2019","unstructured":"Boccitto M, Wolin SL (2019) Ro60 and Y RNAs: structure, functions, and roles in autoimmunity. Crit Rev Biochem Mol Biol 54:133\u2013152. https:\/\/doi.org\/10.1080\/10409238.2019.1608902","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"6091_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/08916930008994077","volume":"32","author":"I G\u00e1l","year":"2000","unstructured":"G\u00e1l I, Lakos G, Zeher M (2000) Comparison of the anti-Ro\/SSA autoantibody profile between patients with primary and secondary Sj\u00f6gren\u2019s syndrome. Autoimmunity 32:89\u201392. https:\/\/doi.org\/10.3109\/08916930008994077","journal-title":"Autoimmunity"},{"key":"6091_CR13","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/l70874","author":"L Deroo","year":"2022","unstructured":"Deroo L, Achten H, De Boeck K, Genbrugge E, Bauters W, Roels D et al (2022) The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB\/La reactivities in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. https:\/\/doi.org\/10.55563\/clinexprheumatol\/l70874","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/art.42789","volume":"76","author":"E Bettacchioli","year":"2024","unstructured":"Bettacchioli E, Saraux A, Tison A, Cornec D, Dueymes M, Foulquier N et al (2024) Association of combined anti-Ro52\/TRIM21 and anti-Ro60\/SSA antibodies with increased Sj\u00f6gren disease severity through interferon pathway activation. Arthritis Rheumatol 76:751\u2013762. https:\/\/doi.org\/10.1002\/art.42789","journal-title":"Arthritis Rheumatol"},{"key":"6091_CR15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/acr.24597","volume":"74","author":"B Arma\u011fan","year":"2022","unstructured":"Arma\u011fan B, Robinson SA, Bazoberry A, Perin J, Grader-Beck T, Akpek EK et al (2022) Antibodies to both Ro52 and Ro60 for identifying Sj\u00f6gren\u2019s syndrome patients best suited for clinical trials of disease-modifying therapies. Arthritis Care Res (Hoboken) 74:1559\u20131565. https:\/\/doi.org\/10.1002\/acr.24597","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6091_CR16","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fimmu.2019.00444","volume":"10","author":"A Robbins","year":"2019","unstructured":"Robbins A, Hentzien M, Toquet S, Didier K, Servettaz A, Pham BN et al (2019) Diagnostic utility of separate anti-Ro60 and anti-Ro52\/TRIM21 antibody detection in autoimmune diseases. Front Immunol 10:444. https:\/\/doi.org\/10.3389\/fimmu.2019.00444","journal-title":"Front Immunol"},{"key":"6091_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13075-024-03459-7","volume":"26","author":"X Zhang","year":"2024","unstructured":"Zhang X, Liao Z, Chen Y, Lu H, Wang A, Shi Y et al (2024) A non-invasive model for diagnosis of primary Sj\u00f6gren\u2019s disease based on salivary biomarkers, serum autoantibodies, and Schirmer\u2019s test. Arthritis Res Ther 26:59. https:\/\/doi.org\/10.1186\/s13075-024-03459-7","journal-title":"Arthritis Res Ther"},{"key":"6091_CR18","doi-asserted-by":"publisher","first-page":"105895","DOI":"10.1016\/j.rmed.2020.105895","volume":"163","author":"C Buvry","year":"2020","unstructured":"Buvry C, Cassagnes L, Tekath M, Artigues M, Pereira B, Rieu V et al (2020) Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sj\u00f6gren syndrome. Respir Med 163:105895. https:\/\/doi.org\/10.1016\/j.rmed.2020.105895","journal-title":"Respir Med"},{"key":"6091_CR19","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","volume":"37","author":"X Dong","year":"2018","unstructured":"Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q et al (2018) Distinguishing features of chest HRCT and clinical manifestations in primary Sj\u00f6gren\u2019s syndrome-related interstitial lung disease. Clin Rheumatol 37:2981\u20132988. https:\/\/doi.org\/10.1007\/s10067-018-4289-6","journal-title":"Clin Rheumatol"},{"key":"6091_CR20","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.3390\/jcm13123510","volume":"13","author":"J Gamazo-Herrero","year":"2024","unstructured":"Gamazo-Herrero J, Medina-Luezas JA, Cusacovich I, Mart\u00edn-Asenjo M, Gonz\u00e1lez-Montagut-G\u00f3mez C, S\u00e1nchez-Gonz\u00e1lez MD et al (2024) Rhythm disturbances in adults with systemic autoimmune diseases and anti-Ro52 antibodies. J Clin Med 13:3510. https:\/\/doi.org\/10.3390\/jcm13123510","journal-title":"J Clin Med"},{"key":"6091_CR21","first-page":"686","volume":"30","author":"S Retamozo","year":"2012","unstructured":"Retamozo S, Akasbi M, Brito-Zer\u00f3n P, Bosch X, Bove A, Perez-de-Lis M et al (2012) Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 30:686\u2013692","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR22","doi-asserted-by":"publisher","first-page":"1115548","DOI":"10.3389\/fimmu.2023.1115548","volume":"14","author":"AYS Lee","year":"2023","unstructured":"Lee AYS, Putty T, Lin MW, Swaminathan S, Suan D, Chataway T et al (2023) Isolated anti-Ro52 identifies a severe subset of Sj\u00f6gren\u2019s syndrome patients. Front Immunol 14:1115548. https:\/\/doi.org\/10.3389\/fimmu.2023.1115548","journal-title":"Front Immunol"},{"key":"6091_CR23","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1007\/s10067-022-06299-5","volume":"41","author":"AYS Lee","year":"2022","unstructured":"Lee AYS, Lin MW, Reed JH (2022) Anti-Ro52\/TRIM21 serological subsets identify differential clinical and laboratory parameters. Clin Rheumatol 41:3495\u20133501. https:\/\/doi.org\/10.1007\/s10067-022-06299-5","journal-title":"Clin Rheumatol"},{"key":"6091_CR24","doi-asserted-by":"publisher","first-page":"e003666","DOI":"10.1136\/rmdopen-2023-003666","volume":"10","author":"S Chiang","year":"2024","unstructured":"Chiang S, Grogan T, Kamounah S, Wei F, Tayob N, Kim JY et al (2024) Distinctive profile of monomeric and polymeric anti-SSA\/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sj\u00f6gren\u2019s syndrome and sicca. RMD Open 10:e003666. https:\/\/doi.org\/10.1136\/rmdopen-2023-003666","journal-title":"RMD Open"},{"key":"6091_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10875-010-9397-2","volume":"30","author":"RC Monteiro","year":"2010","unstructured":"Monteiro RC (2010) The role of IgA and IgA Fc receptors as anti-inflammatory agents. J Clin Immunol 30:61\u201364. https:\/\/doi.org\/10.1007\/s10875-010-9397-2","journal-title":"J Clin Immunol"},{"issue":"Suppl 126","key":"6091_CR26","first-page":"85","volume":"38","author":"N Acar-Denizli","year":"2020","unstructured":"Acar-Denizli N, Horv\u00e1th IF, Mandl T, Priori R, Vissink A, Hernandez-Molina G et al (2020) Systemic phenotype related to primary Sj\u00f6gren\u2019s syndrome in patients carrying isolated anti-La\/SSB antibodies. Clin Exp Rheumatol 38(Suppl 126):85\u201394","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 126","key":"6091_CR27","first-page":"53","volume":"38","author":"G Cafaro","year":"2020","unstructured":"Cafaro G, Perricone C, Baldini C, Quartuccio L, Priori R, Carubbi F et al (2020) Significance of anti-La\/SSB antibodies in primary Sj\u00f6gren\u2019s syndrome patients with combined positivity for anti-Ro\/SSA and salivary gland biopsy. Clin Exp Rheumatol 38(Suppl 126):53\u201356","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR28","doi-asserted-by":"publisher","first-page":"726598","DOI":"10.1155\/2013\/726598","volume":"2013","author":"F Ingegnoli","year":"2013","unstructured":"Ingegnoli F, Castelli R, Gualtierotti R (2013) Rheumatoid factors: clinical applications. Dis Markers 2013:726598. https:\/\/doi.org\/10.1155\/2013\/726598","journal-title":"Dis Markers"},{"key":"6091_CR29","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00296-020-04782-3","volume":"41","author":"M Ma\u015bli\u0144ska","year":"2021","unstructured":"Ma\u015bli\u0144ska M, Ma\u0144czak M, Kwiatkowska B, Ramsperger V, Shen L, Suresh L (2021) IgA immunoglobulin isotype of rheumatoid factor in primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int 41:643\u2013649. https:\/\/doi.org\/10.1007\/s00296-020-04782-3","journal-title":"Rheumatol Int"},{"key":"6091_CR30","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00784-018-2545-4","volume":"23","author":"K-A Lee","year":"2019","unstructured":"Lee K-A, Kim K-W, Kim B-M, Won J-Y, Kim H-A, Moon H-W et al (2019) Clinical and diagnostic significance of serum immunoglobulin A rheumatoid factor in primary Sj\u00f6gren\u2019s syndrome. Clin Oral Investig 23:1415\u20131423. https:\/\/doi.org\/10.1007\/s00784-018-2545-4","journal-title":"Clin Oral Investig"},{"key":"6091_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/art.39518","volume":"68","author":"G Nocturne","year":"2016","unstructured":"Nocturne G, Virone A, Ng WF, Le Guern V, Hachulla E, Cornec D et al (2016) Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 68:977\u2013985. https:\/\/doi.org\/10.1002\/art.39518","journal-title":"Arthritis Rheumatol"},{"key":"6091_CR32","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s10067-019-04438-z","volume":"38","author":"M Ma\u015bli\u0144ska","year":"2019","unstructured":"Ma\u015bli\u0144ska M, Ma\u0144czak M, Kwiatkowska B (2019) Usefulness of rheumatoid factor as an immunological and prognostic marker in primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol 38:1301\u20131307. https:\/\/doi.org\/10.1007\/s10067-019-04438-z","journal-title":"Clin Rheumatol"},{"key":"6091_CR33","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.1038\/s41598-018-24279-1","volume":"8","author":"H Yang","year":"2018","unstructured":"Yang H, Bian S, Chen H, Wang L, Zhao L, Zhang X et al (2018) Clinical characteristics and risk factors for overlapping rheumatoid arthritis and Sj\u00f6gren\u2019s syndrome. Sci Rep 8:6186. https:\/\/doi.org\/10.1038\/s41598-018-24279-1","journal-title":"Sci Rep"},{"key":"6091_CR34","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.7150\/ijbs.63556","volume":"17","author":"G Qiao","year":"2021","unstructured":"Qiao G, Wu A, Chen X, Tian Y, Lin X (2021) Enolase 1 as a potential target for cancer treatment. Int J Biol Sci 17:3981\u20133992. https:\/\/doi.org\/10.7150\/ijbs.63556","journal-title":"Int J Biol Sci"},{"key":"6091_CR35","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.21037\/gs-20-814","volume":"9","author":"P Wei","year":"2020","unstructured":"Wei P, Xing Y, Li B, Chen F, Hua H (2020) Proteomics-based analysis indicating \u03b1-enolase as a potential biomarker in primary Sj\u00f6gren\u2019s syndrome. Gland Surg 9:2054\u20132063. https:\/\/doi.org\/10.21037\/gs-20-814","journal-title":"Gland Surg"},{"key":"6091_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2017.09.012","volume":"183","author":"A Nezos","year":"2017","unstructured":"Nezos A, Cinoku I, Mavragani CP, Moutsopoulos HM (2017) Antibodies against citrullinated alpha-enolase peptides in primary Sj\u00f6gren\u2019s syndrome. Clin Immunol 183:300\u2013303. https:\/\/doi.org\/10.1016\/j.clim.2017.09.012","journal-title":"Clin Immunol"},{"issue":"Suppl 118","key":"6091_CR37","first-page":"29","volume":"37","author":"E Olivares-Mart\u00ednez","year":"2019","unstructured":"Olivares-Mart\u00ednez E, Hern\u00e1ndez-Ram\u00edrez DF, N\u00fa\u00f1ez-\u00c1lvarez CA, Llorente L, Hernandez-Molina G (2019) \u03b1-Enolase is an antigenic target in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 37(Suppl 118):29\u201335","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR38","doi-asserted-by":"publisher","first-page":"30039","DOI":"10.18632\/oncotarget.15613","volume":"8","author":"L Cui","year":"2017","unstructured":"Cui L, Elzakra N, Xu S, Xiao GG, Yang Y, Hu S (2017) Investigation of three potential autoantibodies in Sj\u00f6gren\u2019s syndrome and associated MALT lymphoma. Oncotarget 8:30039\u201330049. https:\/\/doi.org\/10.18632\/oncotarget.15613","journal-title":"Oncotarget"},{"key":"6091_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.rcreue.2018.11.002","volume":"26","author":"C Arteaga","year":"2019","unstructured":"Arteaga C, Barrera C, Morales G, Barrera N, Prieto N (2019) Alpha fodrin and the diagnosis of primary Sj\u00f6gren\u2019s syndrome. Rev Colomb Reumatol (Engl Ed) 26:4\u201310. https:\/\/doi.org\/10.1016\/j.rcreue.2018.11.002","journal-title":"Rev Colomb Reumatol (Engl Ed)"},{"key":"6091_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1126\/science.276.5312.604","volume":"276","author":"N Haneji","year":"1997","unstructured":"Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I et al (1997) Identification of \u03b1-fodrin as a candidate autoantigen in primary Sj\u00f6gren\u2019s syndrome. Science 276:604\u2013607. https:\/\/doi.org\/10.1126\/science.276.5312.604","journal-title":"Science"},{"key":"6091_CR41","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.clinbiochem.2013.04.020","volume":"46","author":"Q Hu","year":"2013","unstructured":"Hu Q, Wang D, Chen W (2013) The accuracy of the anti-\u03b1-fodrin antibody test for diagnosis of Sj\u00f6gren\u2019s syndrome: a meta-analysis. Clin Biochem 46:1372\u20131376. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.04.020","journal-title":"Clin Biochem"},{"key":"6091_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/abr.abr_260_20","volume":"11","author":"A Rostamian","year":"2022","unstructured":"Rostamian A, Baradaran A, Mottaghi P, Salesi M, Karimifar M, Mansouri V (2022) Evaluation of diagnostic accuracy of alpha-fodrin antibody in Iranian patients with Sj\u00f6gren\u2019s disease. Adv Biomed Res 11:64. https:\/\/doi.org\/10.4103\/abr.abr_260_20","journal-title":"Adv Biomed Res"},{"key":"6091_CR43","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/ar1021","volume":"6","author":"MM Zandbelt","year":"2003","unstructured":"Zandbelt MM, Vogelzangs J, van de Putte LBA, van Venrooij WJ, van den Hoogen FHJ (2003) Anti-\u03b1-fodrin antibodies do not add much to the diagnosis of Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther 6:R33\u2013R38. https:\/\/doi.org\/10.1186\/ar1021","journal-title":"Arthritis Res Ther"},{"key":"6091_CR44","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/rheumatology\/kex328","volume":"56","author":"JS Tzartos","year":"2017","unstructured":"Tzartos JS, Stergiou C, Daoussis D, Zisimopoulou P, Andonopoulos AP, Zolota V et al (2017) Antibodies to aquaporins are frequent in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 56:2114\u20132122. https:\/\/doi.org\/10.1093\/rheumatology\/kex328","journal-title":"Rheumatology (Oxford)"},{"key":"6091_CR45","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12026-016-8786-x","volume":"64","author":"J Alam","year":"2016","unstructured":"Alam J, Koh JH, Kim N, Kwok SK, Park SH, Song YW et al (2016) Detection of autoantibodies against aquaporin-5 in the sera of patients with primary Sj\u00f6gren\u2019s syndrome. Immunol Res 64:848\u2013856. https:\/\/doi.org\/10.1007\/s12026-016-8786-x","journal-title":"Immunol Res"},{"key":"6091_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1405126","author":"W Qi","year":"2024","unstructured":"Qi W, Tian J, Wang G, Yan Y, Wang T, Wei Y et al (2024) Advances in cellular and molecular pathways of salivary gland damage in Sj\u00f6gren\u2019s syndrome. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1405126","journal-title":"Front Immunol"},{"key":"6091_CR47","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3390\/jcm8111863","volume":"8","author":"S Jeon","year":"2019","unstructured":"Jeon S, Lee J, Park SH, Kim HD, Choi Y (2019) Associations of anti-aquaporin 5 autoantibodies with serologic and histopathological features of Sj\u00f6gren\u2019s syndrome. J Clin Med 8:1863. https:\/\/doi.org\/10.3390\/jcm8111863","journal-title":"J Clin Med"},{"key":"6091_CR48","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s10067-024-07190-1","volume":"43","author":"X Wang","year":"2024","unstructured":"Wang X, Wu H, Zhong B, Zhang L, Wang Y (2024) Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol 43:3781\u20133787. https:\/\/doi.org\/10.1007\/s10067-024-07190-1","journal-title":"Clin Rheumatol"},{"key":"6091_CR49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4110\/in.2017.17.2.103","volume":"17","author":"J Alam","year":"2017","unstructured":"Alam J, Choi YS, Koh JH, Kwok SK, Park SH, Song YW et al (2017) Detection of autoantibodies against aquaporin-1 in the sera of patients with primary Sj\u00f6gren\u2019s syndrome. Immune Netw 17:103\u2013109. https:\/\/doi.org\/10.4110\/in.2017.17.2.103","journal-title":"Immune Netw"},{"key":"6091_CR50","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/rheumatology\/keh672","volume":"44","author":"L Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs L, Marczinovits I, Gy\u00f6rgy A, T\u00f3th GK, Dorgai L, P\u00e1l J et al (2005) Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213\u2013228) in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 44:1021\u20131025. https:\/\/doi.org\/10.1093\/rheumatology\/keh672","journal-title":"Rheumatology (Oxford)"},{"key":"6091_CR51","doi-asserted-by":"publisher","first-page":"9579","DOI":"10.1073\/pnas.97.17.9579","volume":"97","author":"M Matsui","year":"2000","unstructured":"Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y et al (2000) Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci U S A 97:9579\u20139584. https:\/\/doi.org\/10.1073\/pnas.97.17.9579","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6091_CR52","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/1529-0131(200010)43:10","volume":"43","author":"KH Nguyen","year":"2000","unstructured":"Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G et al (2000) Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum 43:2297\u20132306. https:\/\/doi.org\/10.1002\/1529-0131(200010)43:10","journal-title":"Arthritis Rheum"},{"key":"6091_CR53","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1073\/pnas.95.13.7538","volume":"95","author":"CP Robinson","year":"1998","unstructured":"Robinson CP, Brayer J, Yamachika S, Esch TR, Peck AB, Stewart CA et al (1998) Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sj\u00f6gren\u2019s syndrome. Proc Natl Acad Sci U S A 95:7538\u20137543. https:\/\/doi.org\/10.1073\/pnas.95.13.7538","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6091_CR54","doi-asserted-by":"publisher","first-page":"795","DOI":"10.55563\/clinexprheumatol\/gy6udz","volume":"39","author":"M Mona","year":"2021","unstructured":"Mona M, Mondello S, Hyon JY, Saleh W, Han K, Lee HJ et al (2021) Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 39:795\u2013803. https:\/\/doi.org\/10.55563\/clinexprheumatol\/gy6udz","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR55","first-page":"322","volume":"30","author":"J He","year":"2012","unstructured":"He J, Qiang L, Ding Y, Wei P, Li YN, Hua H et al (2012) The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205\u2013220) antibody in the saliva of patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 30:322\u2013326","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jim.2016.07.003","volume":"437","author":"J Zuo","year":"2016","unstructured":"Zuo J, Williams AEG, Park YJ, Choi K, Chan AL, Reeves WH et al (2016) Muscarinic type 3 receptor autoantibodies are associated with anti-SSA\/Ro autoantibodies in Sj\u00f6gren\u2019s syndrome. J Immunol Methods 437:28\u201336. https:\/\/doi.org\/10.1016\/j.jim.2016.07.003","journal-title":"J Immunol Methods"},{"key":"6091_CR57","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.molimm.2017.07.007","volume":"90","author":"E Namkoong","year":"2017","unstructured":"Namkoong E, Lee S, Kim N, Choi Y, Park K (2017) Effect of anti-muscarinic autoantibodies on leukocyte function in Sj\u00f6gren\u2019s syndrome. Mol Immunol 90:136\u2013142. https:\/\/doi.org\/10.1016\/j.molimm.2017.07.007","journal-title":"Mol Immunol"},{"key":"6091_CR58","doi-asserted-by":"publisher","unstructured":"Fakher HE, El Gazzar NM, Mabrouk MM, Nada DW (2023) Serum muscarinic acetylcholine receptor subtype 3 (M3AChR)-specific autoantibodies in patients with rheumatoid arthritis associated with Sj\u00f6gren\u2019s syndrome. BMC Rheumatol. https:\/\/doi.org\/10.1186\/s41927-023-00368-1","DOI":"10.1186\/s41927-023-00368-1"},{"key":"6091_CR59","doi-asserted-by":"publisher","first-page":"e0116744","DOI":"10.1371\/journal.pone.0116744","volume":"10","author":"C Deng","year":"2015","unstructured":"Deng C, Hu C, Chen S, Li J, Wen X, Wu Z et al (2015) Meta-analysis of anti-muscarinic receptor type 3 antibodies for the diagnosis of Sj\u00f6gren syndrome. PLoS ONE 10:e0116744. https:\/\/doi.org\/10.1371\/journal.pone.0116744","journal-title":"PLoS ONE"},{"key":"6091_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.clim.2012.09.013","volume":"145","author":"L Shen","year":"2012","unstructured":"Shen L, Suresh L, Lindemann M, Xuan J, Kowal P, Malyavantham K et al (2012) Novel autoantibodies in Sj\u00f6gren\u2019s syndrome. Clin Immunol 145:251\u2013255. https:\/\/doi.org\/10.1016\/j.clim.2012.09.013","journal-title":"Clin Immunol"},{"key":"6091_CR61","doi-asserted-by":"publisher","unstructured":"Jin Y, Li J, Chen J, Shao M, Zhang R, Liang Y et al (2019) Tissue-specific autoantibodies improve diagnosis of primary Sj\u00f6gren\u2019s syndrome in the early stage and indicate localized salivary injury. J Immunol Res 2019:3642937. https:\/\/doi.org\/10.1155\/2019\/3642937","DOI":"10.1155\/2019\/3642937"},{"key":"6091_CR62","doi-asserted-by":"publisher","unstructured":"Everett S, Vishwanath S, Cavero V, Shen L, Suresh L, Malyavantham K et al (2017) Analysis of novel Sj\u00f6gren\u2019s syndrome autoantibodies in patients with dry eyes. BMC Ophthalmol. https:\/\/doi.org\/10.1186\/s12886-017-0412-8","DOI":"10.1186\/s12886-017-0412-8"},{"key":"6091_CR63","doi-asserted-by":"publisher","unstructured":"Suresh L, Malyavantham K, Shen L, Ambrus JL (2015) Investigation of novel autoantibodies in Sj\u00f6gren\u2019s syndrome utilizing sera from the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. BMC Ophthalmol. https:\/\/doi.org\/10.1186\/s12886-015-0023-1","DOI":"10.1186\/s12886-015-0023-1"},{"key":"6091_CR64","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/ICO.0000000000001471","volume":"37","author":"S Karakus","year":"2018","unstructured":"Karakus S, Baer AN, Agrawal D, Gurakar M, Massof RW, Akpek EK (2018) Utility of novel autoantibodies in the diagnosis of Sj\u00f6gren\u2019s syndrome among patients with dry eye. Cornea 37:405\u2013411. https:\/\/doi.org\/10.1097\/ICO.0000000000001471","journal-title":"Cornea"},{"key":"6091_CR65","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.55563\/clinexprheumatol\/tt1e0x","volume":"43","author":"ZM Wang","year":"2025","unstructured":"Wang ZM, Yang YS, Qi X, Zhang Y, Wang XP, Li JL et al (2025) Comparison and clinical analysis of tissue-specific autoantibody levels in primary Sj\u00f6gren\u2019s disease and other connective tissue diseases. Clin Exp Rheumatol 43:2060\u20132068. https:\/\/doi.org\/10.55563\/clinexprheumatol\/tt1e0x","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR66","doi-asserted-by":"publisher","unstructured":"Karakus S, Baer AN, Akpek EK (2019) Clinical correlations of novel autoantibodies in patients with dry eye. J Immunol Res. https:\/\/doi.org\/10.1155\/2019\/7935451","DOI":"10.1155\/2019\/7935451"},{"key":"6091_CR67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/J.CLIM.2014.08.009","volume":"155","author":"L Shen","year":"2014","unstructured":"Shen L, Kapsogeorgou EK, Yu M, Suresh L, Malyavantham K, Tzioufas AG et al (2014) Evaluation of salivary gland protein 1 antibodies in patients with primary and secondary Sj\u00f6gren\u2019s syndrome. Clin Immunol 155:42\u201346. https:\/\/doi.org\/10.1016\/J.CLIM.2014.08.009","journal-title":"Clin Immunol"},{"key":"6091_CR68","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1097\/ICO.0000000000002147","volume":"38","author":"VY Bunya","year":"2019","unstructured":"Bunya VY, Massaro-Giordano M, Vivino FB, Maguire MG, Baer AN, Gonzales JA et al (2019) Prevalence of novel candidate Sj\u00f6gren syndrome autoantibodies in the Penn Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Cornea 38:1500\u20131505. https:\/\/doi.org\/10.1097\/ICO.0000000000002147","journal-title":"Cornea"},{"key":"6091_CR69","doi-asserted-by":"publisher","unstructured":"Thatayatikom A, Jun I, Bhattacharyya I, Berg K, Lee YJ, Kim Y et al (2021) The diagnostic performance of early Sj\u00f6gren\u2019s syndrome autoantibodies in juvenile Sj\u00f6gren\u2019s syndrome. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.704193","DOI":"10.3389\/fimmu.2021.704193"},{"key":"6091_CR70","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s12325-017-0501-3","volume":"34","author":"KA Beckman","year":"2017","unstructured":"Beckman KA, Luchs J, Milner MS, Ambrus JL (2017) The potential role for early biomarker testing as part of a modern, multidisciplinary approach to Sj\u00f6gren\u2019s syndrome diagnosis. Adv Ther 34:799\u2013812. https:\/\/doi.org\/10.1007\/s12325-017-0501-3","journal-title":"Adv Ther"},{"key":"6091_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1613263","author":"EN Anuwa-Amarh","year":"2025","unstructured":"Anuwa-Amarh EN, Ziemanski JF (2025) Meibomian gland dysfunction in Sj\u00f6gren\u2019s disease. Front Med (Lausanne). https:\/\/doi.org\/10.3389\/fmed.2025.1613263","journal-title":"Front Med (Lausanne)"},{"key":"6091_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7258(96)00198-2","volume":"74","author":"S Lindskog","year":"1997","unstructured":"Lindskog S (1997) Structure and mechanism of carbonic anhydrase. Pharmacol Ther 74:1\u201320. https:\/\/doi.org\/10.1016\/S0163-7258(96)00198-2","journal-title":"Pharmacol Ther"},{"key":"6091_CR73","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/J.AMJMED.2004.07.049","volume":"118","author":"F Takemoto","year":"2005","unstructured":"Takemoto F, Hoshino J, Sawa N, Tamura Y, Tagami T, Yokota M et al (2005) Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sj\u00f6gren syndrome. Am J Med 118:181\u2013184. https:\/\/doi.org\/10.1016\/J.AMJMED.2004.07.049","journal-title":"Am J Med"},{"key":"6091_CR74","doi-asserted-by":"publisher","first-page":"e32673","DOI":"10.1097\/MD.0000000000032673","volume":"102","author":"YB Jin","year":"2023","unstructured":"Jin YB, Dai YJ, Chen JL, Li J, Zhang X, Sun XL et al (2023) Anti-carbonic anhydrase II antibody reflects urinary acidification defect especially in proximal renal tubules in patients with primary Sj\u00f6gren syndrome. Medicine (Baltim) 102:e32673. https:\/\/doi.org\/10.1097\/MD.0000000000032673","journal-title":"Medicine (Baltim)"},{"key":"6091_CR75","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/rheumatology\/ker118","volume":"50","author":"M Pertovaara","year":"2011","unstructured":"Pertovaara M, Bootorabi F, Kuuslahti M, Pasternack A, Parkkila S (2011) Novel carbonic anhydrase autoantibodies and renal manifestations in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatology 50:1453\u20131457. https:\/\/doi.org\/10.1093\/rheumatology\/ker118","journal-title":"Rheumatology"},{"key":"6091_CR76","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1002\/art.38852","volume":"66","author":"MB Lauvsnes","year":"2014","unstructured":"Lauvsnes MB, Beyer MK, Kval\u00f8y JT, Greve OJ, Appenzeller S, Kvivik I et al (2014) Association of hippocampal atrophy with cerebrospinal fluid antibodies against the NR2 subtype of the N-methyl-D-aspartate receptor in patients with systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 66:3387\u20133394. https:\/\/doi.org\/10.1002\/art.38852","journal-title":"Arthritis Rheumatol"},{"key":"6091_CR77","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1002\/art.38127","volume":"65","author":"MB Lauvsnes","year":"2013","unstructured":"Lauvsnes MB, Maroni SS, Appenzeller S, Beyer MK, Greve OJ, Kval\u00f8y JT et al (2013) Memory dysfunction in primary Sj\u00f6gren\u2019s syndrome is associated with anti-NR2 antibodies. Arthritis Rheum 65:3209\u20133217. https:\/\/doi.org\/10.1002\/art.38127","journal-title":"Arthritis Rheum"},{"key":"6091_CR78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.autrev.2016.12.002","volume":"16","author":"SH Tay","year":"2017","unstructured":"Tay SH, Fairhurst AM, Mak A (2017) Clinical utility of circulating anti-N-methyl-D-aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: an updated meta-analysis. Autoimmun Rev 16:114\u2013122. https:\/\/doi.org\/10.1016\/j.autrev.2016.12.002","journal-title":"Autoimmun Rev"},{"key":"6091_CR79","doi-asserted-by":"publisher","first-page":"19854","DOI":"10.1073\/pnas.0608397104","volume":"103","author":"C Kowal","year":"2006","unstructured":"Kowal C, DeGiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT et al (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 103:19854\u201319859. https:\/\/doi.org\/10.1073\/pnas.0608397104","journal-title":"Proc Natl Acad Sci USA"},{"key":"6091_CR80","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00415-020-10290-y","volume":"268","author":"AB Tjensvoll","year":"2021","unstructured":"Tjensvoll AB, Lauvsnes MB, Zetterberg H, Kval\u00f8y JT, Kvivik I, Maroni SS et al (2021) Neurofilament light is a biomarker of brain involvement in lupus and primary Sj\u00f6gren\u2019s syndrome. J Neurol 268:1385\u20131394. https:\/\/doi.org\/10.1007\/s00415-020-10290-y","journal-title":"J Neurol"},{"key":"6091_CR81","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P, Di Filippo M, Parnetti L, Zetterberg H (2019) Neurofilament light chain as a biomarker in neurological disorders. J Neurol Neurosurg Psychiatry 90:870\u2013881. https:\/\/doi.org\/10.1136\/jnnp-2018-320106","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6091_CR82","doi-asserted-by":"publisher","unstructured":"Marinoska T, M\u00f6ckel T, Triantafyllias K, Boegel S, Dreher M, Luessi F et al (2023) NMDA receptors in health and disease: anti-N-methyl-D-aspartate receptor autoantibodies as potential biomarkers of fatigue in rheumatic diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24043560","DOI":"10.3390\/ijms24043560"},{"key":"6091_CR83","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/s00415-020-10377-6","volume":"268","author":"T Akaishi","year":"2021","unstructured":"Akaishi T, Takahashi T, Fujihara K, Misu T, Fujimori J, Takai Y et al (2021) Impact of comorbid Sj\u00f6gren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. J Neurol 268:1938\u20131944. https:\/\/doi.org\/10.1007\/s00415-020-10377-6","journal-title":"J Neurol"},{"key":"6091_CR84","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1055\/s-0043-1777105","volume":"81","author":"OGP Barsottini","year":"2023","unstructured":"Barsottini OGP, Moraes MPM, Fraiman PHA, Marussi VHR, Souza AWS, Braga Neto P et al (2023) Sj\u00f6gren\u2019s syndrome: a neurological perspective. Arq Neuropsiquiatr 81:1077\u20131083. https:\/\/doi.org\/10.1055\/s-0043-1777105","journal-title":"Arq Neuropsiquiatr"},{"key":"6091_CR85","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1590\/0004-282X20140097","volume":"72","author":"DC Carvalho","year":"2014","unstructured":"Carvalho DC, Tironi TS, Freitas DS, Kleinpaul R, Talim NC, Lana-Peixoto MA (2014) Sj\u00f6gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu. Arq Neuropsiquiatr 72:619\u2013624. https:\/\/doi.org\/10.1590\/0004-282X20140097","journal-title":"Arq Neuropsiquiatr"},{"key":"6091_CR86","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/25785826.2021.1919342","volume":"44","author":"H Nakamura","year":"2021","unstructured":"Nakamura H, Morimoto S, Shimizu T, Takatani A, Nishihata S, Kawakami A (2021) Clinical manifestations in anti-Ro52\/SS-A antibody-seropositive patients with Sj\u00f6gren\u2019s syndrome. Immunol Med 44:252\u2013262. https:\/\/doi.org\/10.1080\/25785826.2021.1919342","journal-title":"Immunol Med"},{"key":"6091_CR87","doi-asserted-by":"publisher","unstructured":"Veenbergen S, Kozmar A, van Daele PLA, Schreurs MWJ (2022) Autoantibodies in Sj\u00f6gren\u2019s syndrome and its classification criteria. J Transl Autoimmun. https:\/\/doi.org\/10.1016\/j.jtauto.2021.100138","DOI":"10.1016\/j.jtauto.2021.100138"},{"key":"6091_CR88","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/08916934.2016.1196676","volume":"49","author":"K Uomori","year":"2016","unstructured":"Uomori K, Nozawa K, Ikeda K, Doe K, Yamada Y, Yamaguchi A et al (2016) A re-evaluation of anti-NA-14 antibodies in patients with primary Sj\u00f6gren\u2019s syndrome. Autoimmunity 49:347\u2013356. https:\/\/doi.org\/10.1080\/08916934.2016.1196676","journal-title":"Autoimmunity"},{"key":"6091_CR89","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.2741\/3484","volume":"14","author":"K Nozawa","year":"2009","unstructured":"Nozawa K, Ikeda K, Satoh M, Reeves WH, Stewart CM, Li YC et al (2009) Autoantibody to NA14 is an independent marker primarily for Sj\u00f6gren\u2019s syndrome. Front Biosci (Landmark Ed) 14:3733\u20133739. https:\/\/doi.org\/10.2741\/3484","journal-title":"Front Biosci (Landmark Ed)"},{"key":"6091_CR90","doi-asserted-by":"publisher","first-page":"14306","DOI":"10.18632\/oncotarget.14882","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Liao X, Wang Y, Chen S, Sun Y, Lin Q et al (2017) Autoantibody to MDM2: a potential serological marker of primary Sj\u00f6gren\u2019s syndrome. Oncotarget 8:14306\u201314313. https:\/\/doi.org\/10.18632\/oncotarget.14882","journal-title":"Oncotarget"},{"key":"6091_CR91","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1093\/rheumatology\/keaa881","volume":"60","author":"R Arcani","year":"2021","unstructured":"Arcani R, Bertin D, Bardin N, Mazodier K, Jean R, Suchon P et al (2021) Anti-NuMA antibodies: clinical associations and significance in patients with primary Sj\u00f6gren\u2019s syndrome or systemic lupus erythematosus. Rheumatology 60:4074\u20134084. https:\/\/doi.org\/10.1093\/rheumatology\/keaa881","journal-title":"Rheumatology"},{"key":"6091_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/RHU.0000000000000905","volume":"26","author":"P Griffo","year":"2020","unstructured":"Griffo P, Viana VVST, Pasoto SG, Leon EP, Bonfa E (2020) Anti-DNase I antibody: a new serological reactivity in primary Sj\u00f6gren syndrome. J Clin Rheumatol 26:19\u201323. https:\/\/doi.org\/10.1097\/RHU.0000000000000905","journal-title":"J Clin Rheumatol"},{"key":"6091_CR93","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/annrheumdis-2015-207509","volume":"75","author":"DF Fiorentino","year":"2016","unstructured":"Fiorentino DF, Presby M, Baer AN, Petri M, Rieger KE, Soloski M et al (2016) PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 75:1145\u20131151. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207509","journal-title":"Ann Rheum Dis"},{"key":"6091_CR94","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.55563\/clinexprheumatol\/ku7y1q","volume":"42","author":"S Stano","year":"2024","unstructured":"Stano S, Cacciapaglia F, Rinaldi A, Giannotta M, Urgesi E, Natuzzi D et al (2024) Anti-aquaporin-5 and anti-poly-U-binding-factor-60\u00a0kDa protein antibodies in primary Sj\u00f6gren\u2019s disease patients. Clin Exp Rheumatol 42:2420\u20132426. https:\/\/doi.org\/10.55563\/clinexprheumatol\/ku7y1q","journal-title":"Clin Exp Rheumatol"},{"key":"6091_CR95","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s12026-017-8970-7","volume":"65","author":"S Duda","year":"2017","unstructured":"Duda S, Witte T, Stangel M, Adams J, Schmidt RE, Baerlecken NT (2017) Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sj\u00f6gren\u2019s syndrome. Immunol Res 65:1099\u20131102. https:\/\/doi.org\/10.1007\/s12026-017-8970-7","journal-title":"Immunol Res"},{"key":"6091_CR96","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/art.40550","volume":"70","author":"J Birnbaum","year":"2018","unstructured":"Birnbaum J, Hoke A, Lalji A, Calabresi P, Bhargava P, Casciola-Rosen L (2018) Anti-calponin 3 autoantibodies: a newly identified specificity in patients with Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 70:1610\u20131616. https:\/\/doi.org\/10.1002\/art.40550","journal-title":"Arthritis Rheumatol"},{"key":"6091_CR97","doi-asserted-by":"publisher","unstructured":"Bagavant H, Araszkiewicz AM, Rasmussen A, Pezant N, Montgomery C, Scofield RH et al (2023) Anti-vimentin antibodies are associated with higher severity of Sj\u00f6gren\u2019s disease. Clin Immunol 247. https:\/\/doi.org\/10.1016\/j.clim.2023.109243","DOI":"10.1016\/j.clim.2023.109243"},{"key":"6091_CR98","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/art.39497","volume":"68","author":"N Wolska","year":"2016","unstructured":"Wolska N, Rybakowska P, Rasmussen A, Brown M, Montgomery C, Klopocki A et al (2016) Patients with primary Sj\u00f6gren\u2019s syndrome positive for autoantibodies to tripartite motif-containing protein 38 show greater disease severity. Arthritis Rheumatol 68:724\u2013729. https:\/\/doi.org\/10.1002\/art.39497","journal-title":"Arthritis Rheumatol"},{"key":"6091_CR99","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.12659\/MSM.895144","volume":"21","author":"YH Hu","year":"2015","unstructured":"Hu YH, Zhou PF, Long GF, Tian X, Guo YF, Pang AM et al (2015) Elevated plasma P-selectin autoantibodies in primary Sj\u00f6gren syndrome patients with thrombocytopenia. Med Sci Monit 21:3690\u20133695. https:\/\/doi.org\/10.12659\/MSM.895144","journal-title":"Med Sci Monit"},{"key":"6091_CR100","doi-asserted-by":"publisher","first-page":"152488","DOI":"10.1016\/J.SEMARTHRIT.2024.152488","volume":"68","author":"S Chen","year":"2024","unstructured":"Chen S, Qian H, Dai F, Fan G, Lu H, Deng C et al (2024) Detection of anti-calreticulin antibody in the sera of Chinese patients with primary Sj\u00f6gren syndrome. Semin Arthritis Rheum 68:152488. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2024.152488","journal-title":"Semin Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06091-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06091-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:54:55Z","timestamp":1776326095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06091-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,21]]},"references-count":100,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6091"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06091-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,21]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval and informed consent were not required for this systematic review, as it is based exclusively on publicly available, anonymized published data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Written informed consent"}},{"value":"This paper has been prepared by the authors without the involvement of editing agencies. No AI technologies or editing software were utilized in the creation of this work.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Editing agencies involved and the use of AI or editing software"}},{"value":"Artificial intelligence-based language model was employed to improve the grammar, clarity, and linguistic quality of the manuscript. The authors critically reviewed and approved all AI-assisted revisions and confirm that the scientific content, interpretations, and conclusions are entirely their own. The authors declare that this review is original and that no part of the manuscript has been previously published or is under consideration for publication elsewhere, in whole or in part, in any language.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"62"}}